Vapotherm Inc. (VAPO)
Company Description
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally.
The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.
It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors.
In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range.
The company sells its products to hospitals.
Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Country | United States |
IPO Date | Nov 14, 2018 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 182 |
CEO | Joseph F. Army CPA |
Contact Details
Address: 100 Domain Drive Exeter, New Hampshire United States | |
Website | https://www.vapotherm.com |
Stock Details
Ticker Symbol | VAPO |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001253176 |
CUSIP Number | 922107107 |
ISIN Number | IE0003LFZ4U7 |
Employer ID | 00-0000000 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Joseph F. Army CPA | Chief Executive Officer, President & Director |
Brian Lawrence | Senior Vice President & Chief Technology Officer |
John Landry | Senior Vice President, Chief Financial Officer & Treasurer |
Anthony Ten Haagen | Vice President of Legal & Compliance |
Dorota Mckay | Vice President, Controller & Chief Accounting Officer |
Dr. Jessica Whittle M.D., Ph.D. | Chief Medical Officer & Vice President of Clinical Research |
James A. Lightman | Senior Vice President, General Counsel & Secretary |
Lindsay Becker | Vice President of Human Resources |
William Niland | Founder |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 14, 2024 | SCHEDULE 13G | Filing |
Nov 14, 2024 | SCHEDULE 13G/A | [Amend] Filing |
Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Sep 25, 2024 | 15-12G | Filing |
Sep 24, 2024 | SC 13D/A | [Amend] Filing |
Sep 24, 2024 | 4 | Filing |
Sep 24, 2024 | 4 | Filing |